Skip to main content

Table 2 Patient demographics and IVF outcomes, by number of retrieved oocytes

From: Retrospective analysis of GnRH-a prolonged protocol for in vitro fertilization in 18,272 cycles in China

 

Group 1

Group 2

Group 3

F (ANOVA) or χ2 test statistic

P-value

≤ 8 oocytes

9–17 oocytes

≥ 18 oocytes

No. treatment cycles (n)

4870

10,106

3296

  

Age (years), x̄ ± SD

32.40 ± 5.20

30.09 ± 4.69

28.48 ± 4.16

724.77

< 0.0001

BMI (kg/m2), x̄ ± SD

22.06 ± 3.11

21.83 ± 3.02

21.74 ± 3.07

12.36

< 0.0001

AFC, Median [IQR]

9 [6,12]

13 [10,17]

16 [12,20]

2252.7981

< 0.0001

Total dose of gonadotropins (IU), Median [IQR]

2,700 [2,025, 3,525]

2,100 [1,537.5, 2,775]

1,762.5 [1,350, 2,475]

1685.9298

< 0.0001

Duration of ovarian stimulation (days), x̄ ± SD

11.35 ± 2.21

11.70 ± 2.10

12.22 ± 2.46

153

< 0.0001

LH on hCG trigger day (IU/L), Median [IQR]

0.93 [0.6,1.4]

0.88 [0.57,1.36]

0.79 [0.49,1.23]

107.741

< 0.0001

P on hCG trigger day (ng/mL), Median [IQR]

0.658 [0.43, 0.89]

0.82 [0.58, 1.07]

0.98 [0.711, 1.28]

1272.15

< 0.0001

E2 on hCG trigger day (pg/mL), Median [IQR]

1,214 [879.1, 1,670]

2,184 [1,635, 2,913]

3,478 [2,602.22, 4,608.5]

6.943.40

< 0.0001

Endometrial thickness on hCG trigger day (mm), Median [IQR]

10.6 [9, 12.4]

10.9 [9.4, 12.6]

10.8 [9.2, 12.5]

51.1977

< 0.0001

Oocytes retrieved, x̄ ± SD

6.05 ± 1.79

12.53 ± 2.47

22.27 ± 5.01

29,589.6

< 0.0001

No. available embryos, Median [IQR]

2 [1 3]

3[2,4]

5 [3,7]

3742.67

< 0.0001

No. fresh embryos transferred, x̄ ± SD

1.80 ± 0.41

1.86 ± 0.35

1.64 ± 0.48

258.05

< 0.0001

Time to live birth (days), x̄ ± SD

320.96 ± 98.26

330.08 ± 266.13

383.77 ± 187.53

65.79

< 0.0001

Cancellation rate with no available embryos, n (%)

627/4,870 (12.87%)

458/10,106 (4.53%)

80/3,296 (2.43%)

488.223

< 0.0001

Cycle cancellation for high risk of OHSS, n (%)

14/4,870 (0.29%)

305/10,106 (3.02%)

782/3,296 (23.73%)

2268.21

< 0.0001

Moderate-to-severe OHSS rate, n (%)

4/4,870 (0.08%)

211/10,106 (2.09%)

112/3,296 (3.4%)

134.413

< 0.0001

CLBR/cycle started, n (%)

2,314/4,870 (47.52%)

7,143/10,106 (70.68%)

2,717/3,296 (82.43%)

1244.99

< 0.0001

No. fresh transfer cycles (n)

4057

8878

1922

  

No. embryos transferred

   

504.44

< 0.0001

 1

826/4057(20.36%)

1240/8878(13.97%)

685/1922(35.64%)

  

 2

3231/4057(79.64%)

7638/8878(86.03%)

1237/1922(64.36%)

  

Embryo transfer type

   

1610.83

< 0.0001

 Cleavage embryo

3933/4057(96.94%)

8296/8878(93.44%)

1283/1922(66.75%)

  

 Blastocyst

124/4057(3.06%)

582/8878(6.56%)

639/1922(33.25%)

  

HCG positive rate

2713/4057(66.87%)

6889/8878(77.6%)

1561/1922(81.22%)

215.12

< 0.0001

Clinical pregnancy rate

2431/4057(59.92%)

6378/8878(71.84%)

1470/1922(76.48%)

240.7

< 0.0001

Abortion rate

347/2431(14.27%)

557/6378(8.73%)

92/1470(6.26%)

84.83

< 0.0001

Live birth rate

2044/4057(50.38%)

5743/8878(64.69%)

1361/1922(70.81%)

320.48

< 0.0001

  1. The CLBR corresponded to the results of all treatments from 1 complete cycle, including all fresh and frozen–thawed ET cycles from 1 oocyte retrieval, over a time period of 2 years
  2. Available embryos, high-quality embryos for transfering
  3. AFC Antral follicle count, ANOVA Analysis of variance, BMI Body mass index, CLBR Cumulative live birth rate, E2 Estradiol, hCG human choriogonadotropin, IVF In vitro fertilization, LBR Live birth rate, LH Luteinizing hormone, OHSS Ovarian hyperstimulation syndrome, OPU Oocyte pick-up, P Progesterone